News FDA names MDMA a 'breakthrough' for post-traumatic stress US non-profit organisation to begin late-stage trials this year
News AZ to develop Parkinson's drug with Takeda AstraZeneca could receive up to $400 million from Takeda after approaching the company to jointly develop and market a new treatment for Parkinson’s disease (PD).
News GW prepares for 2018 US launch of epilepsy drug But Zynerba's cannabis epilepsy drug fails in phase 2.
News UK patients gain early access to Duchenne drug Patients to get Santhera's Raxone under EAMS scheme.
News ADARx, Trex, and Retension take aim at IPOs The appetite among biotechs for IPOs shows no signs of being satisfied, with three more – ADARx, TRex, and Retension – making their intentions known.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
